Evidence map›Paper›PMID 42593794›Full record

ArticleJAMA network open2026

Timing of 30-Day Hospital Readmission Risk and Its Implications for Clinical Utility.

Mohamad Zafer Alkayali, Yuelei Fu, Janna C Castro, Matt Gill, Shant Ayanian, Sagar B Dugani

Abstract read
In one paragraph

Article in JAMA network open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mohamad Zafer AlkayaliDivision of Hospital Internal Medicine, Mayo Clinic, Rochester, Minnesota.
Yuelei FuCenter for Digital Health, Mayo Clinic, Rochester, Minnesota.
Janna C CastroDepartment of Information Technology, Mayo Clinic, Rochester, Minnesota.
Matt GillCenter for Digital Health, Mayo Clinic, Rochester, Minnesota.
Shant AyanianDivision of Hospital Internal Medicine, Mayo Clinic, Rochester, Minnesota.
Sagar B DuganiDivision of Hospital Internal Medicine, Mayo Clinic, Rochester, Minnesota.

Funding

Rural Patient Risks and Exposures for Diabetes ConTrol (Rural PREDICT)K23MD016230 · NIMHD · MAYO CLINIC ROCHESTER · PI DUGANI, CHANDRASAGAR · 2021 to 2025
$763k
NIMHD NIH HHS K23 MD016230
6 · The paper itself

Abstract

Importance: Thirty-day hospital readmission is used to guide postdischarge care; however, a single binary 30-day estimate does not distinguish when risk occurs from when intervention is most actionable, with implications for allocation of postdischarge resources. Objective: To evaluate time-structured hospital readmission risk within 30 days after discharge and implications for clinical utility. Design, Setting, and Participants: Retrospective prognostic study of adults with hospital discharges from 2017 to 2024 (from 19 hospitals within a US health system for the development cohort) and 2008 to 2019 (from Medical Information Mart for Intensive Care IV for the external cohort) with 30-day follow-up. Analyses were conducted from November 2025 through June 2026. Exposure: Postdischarge prediction window, including landmark intervals of 0 to 7, 8 to 14, 15 to 21, and 22 to 30 days and cumulative horizons through days 7, 14, 21, and 30 after discharge. Main Outcomes and Measures: First all-cause hospital readmission before death during each landmark interval and by each cumulative horizon. Risk estimates were derived using clinical information available at hospital discharge. Performance was assessed using discrimination, calibration, decision curves, and capacity-constrained analyses. Results: Among 617 841 discharges in the development cohort, the median (IQR) patient age was 65 (50-76) years, and 315 220 discharges (51.0%) occurred among female patients. The 30-day readmission rate was 16.3% (95% CI, 16.2%-16.5%), with 68 797 readmissions (68.2%) occurring within 14 days. Cumulative-horizon analyses characterized readmission risk through days 7, 14, 21, and 30, whereas landmark interval-specific analyses showed lower positive predictive values (PPVs) beyond day 7. At 5% intervention capacity, landmark PPVs were 58.3% (95% CI, 57.4%-59.1%) for days 0 to 7, 16.0% (95% CI, 15.5%-16.6%) for days 8 to 14, 14.5% (95% CI, 13.9%-15.0%) for days 15 to 21, and 12.9% (95% CI, 12.4% to 13.5%) for days 22 to 30; numbers needed to prevent 1 readmission were 8.6, 31.3, 34.6, and 38.6, respectively. Conclusions and Relevance: In this prognostic study of adult hospital discharges, hospital readmission risk varied over time and was not captured by a single binary 30-day estimate. These findings suggest that time-structured readmission modeling can characterize when readmission risk occurs, but additional work is needed before such models can reliably guide interventions during specific postdischarge intervals.

Indexed as

Patient DischargePatient ReadmissionAgedFemaleHumansMaleMiddle AgedPrognosisRetrospective StudiesRisk AssessmentTime FactorsUnited States

Identifiers

PMID42593794
PMCPMC13474041

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.